Psychiatry and Clinical Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.6 | Q3 | 28.4% | 0.423 | Q3 | 55.2% |
| 2024 | 0.6 | Q4 | 11.8% | 0.240 | Q3 | 37.8% |
| 2023 | 0.5 | Q4 | 12.8% | 0.220 | Q3 | 38.4% |
| 2022 | 0.7 | Q4 | 14.8% | 0.321 | Q3 | 52.7% |
| 2021 | 1.4 | Q4 | 32.4% | 0.313 | Q3 | 52.7% |
| 2020 | — | — | 0.297 | Q3 | 50.0% | |
| 2019 | — | — | 0.252 | Q3 | 46.7% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2475-0581
ISSN
2475-0573
region
Western Europe
coverage
2017-2025